Evaluation of antimicrobial activity of β-lactam antibiotics by Etest against clinical isolates from 100 medical centers in Japan (2004)
- 1 June 2006
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 55 (2) , 143-148
- https://doi.org/10.1016/j.diagmicrobio.2006.01.001
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Evaluation of dipicolinic acid for detection of IMP- or VIM- type metallo-β-lactamase–producing Pseudomonas aeruginosa clinical isolatesDiagnostic Microbiology and Infectious Disease, 2005
- Metallo-β-Lactamases: the Quiet before the Storm?Clinical Microbiology Reviews, 2005
- Clonal Diversity of Metallo-β-Lactamase-Possessing Pseudomonas aeruginosa in Geographically Diverse Regions of JapanJournal of Clinical Microbiology, 2005
- Role of a Mutation at Position 167 of CTX-M-19 in Ceftazidime HydrolysisAntimicrobial Agents and Chemotherapy, 2004
- Multidrug-Resistant Pseudomonas Aeruginosa Bloodstream Infections: Analysis of Trends in Prevalence and EpidemiologyEmerging Infectious Diseases, 2002
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteriaSeminars in Cell & Developmental Biology, 2001
- In vitro evaluation of cefepime and other broad-spectrum β-lactams in 22 medical centers in Japan: a phase II trial comparing two annual organism samplesDiagnostic Microbiology and Infectious Disease, 1999
- Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in JapanDiagnostic Microbiology and Infectious Disease, 1999
- Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactamThe Lancet, 1994